Who
Daniel M. Bendheim
President and CEO
Company insider
Files Form 4 as: President and CEO, Phibro Animal Health.
In numbers
- Trades disclosed
- 90
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $2.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Apr 2014
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —11,699 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —11,699 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $18K486 at $36.60 | filing |
| 4 Aug 2026filed 6 Aug 2026 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code J | $18K486 at $36.60 | filing |
| 1 Jul 2026filed 2 Jul 2026 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code A | —3,964 at $0.00 | filing |
| 30 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,390 at $0.00 | filing |
| 30 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $28K2,390 at $11.83 | filing |
| 30 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $74K2,390 at $31.15 | filing |
| 29 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,890 at $0.00 | filing |
| 29 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $58K4,890 at $11.83 | filing |
| 29 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $153K4,890 at $31.32 | filing |
| 28 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 28 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $30K2,500 at $11.83 | filing |
| 28 Jan 2019filed 30 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $79K2,500 at $31.55 | filing |
| 24 Jan 2019filed 24 Jan 2019 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
| 24 Jan 2019filed 24 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Code M | $30K2,500 at $11.83 | filing |
| 24 Jan 2019filed 24 Jan 2019 | PAHC Phibro Animal HealthPharmaceuticals | SEC FORM 4 Sold | $79K2,500 at $31.78 | filing |
| 23 Jan 2019filed 24 Jan 2019 | PAHC Phibro Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,500 at $0.00 | filing |
News
MediciNova (NASDAQ:MNOV) & Phibro Animal Health (NASDAQ:PAHC) Head to Head ComparisonPAHC · themarketsdaily.com · 14 Oct 2026Contrasting Phibro Animal Health (NASDAQ:PAHC) and Tvardi Therapeutics (NASDAQ:TVRD)PAHC · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Daniel M. Bendheim; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.